Biologic injectable formulation of interferon beta-1a provided by biotech suppliers to neurology clinics and hospitals for multiple sclerosis management. Administered subcutaneously by healthcare professionals in outpatient and inpatient settings for immunomodulatory applications in chronic neurological conditions.